<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="ibm" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">ibm</book-part-id>
      <title-group>
        <title>
<italic toggle="yes">GNE</italic>-Related Myopathy</title>
        <alt-title alt-title-type="alt-title">Synonyms: Distal Myopathy with Rimmed Vacuoles (DMRV), Hereditary Inclusion Body Myopathy 2 (HIBM), Nonaka Myopathy</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>O&#x02019;Ferrall</surname>
            <given-names>Erin K</given-names>
          </name>
          <degrees>MD, MSc, FRCPC</degrees>
          <email>erin.oferrall@mcgill.ca</email>
          <aff>Neuromuscular Research Department<break/>Montreal Neurological Institute<break/>Montreal, Quebec</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sinnreich</surname>
            <given-names>Michael</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <email>michael_sinnreich@hotmail.com</email>
          <aff>Department of Neurology<break/>Neuromuscular Center<break/>University Hospital Basel<break/>Basel, Switzerland</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2004-03-26" date-type="created">
          <day>26</day>
          <month>3</month>
          <year>2004</year>
        </date>
        <date iso-8601-date="2013-03-07" date-type="updated">
          <day>7</day>
          <month>3</month>
          <year>2013</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="gm1-ganglio" document-type="chapter"><italic toggle="yes">GLB1-</italic>Related Disorders</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="grin2a-dis" document-type="chapter"><italic toggle="yes">GRIN2A</italic>-Related Speech Disorders and Epilepsy</related-object>
      <abstract id="ibm.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">GNE</italic>-related myopathy, also known as inclusion body myopathy 2, is characterized by slowly progressive distal muscle weakness that begins in the late teens to early adult years with gait disturbance and foot drop secondary to anterior tibialis muscle weakness. Weakness eventually includes the hand and thigh muscles but commonly spares the quadriceps muscles, even in advanced disease. Affected individuals are usually wheelchair bound about 20 years after onset. If quadriceps sparing is incomplete, loss of ambulation tends to occur earlier.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of <italic toggle="yes">GNE</italic>-related myopathy is based on clinical and histopathologic criteria. Because simplex cases (i.e. a single occurrence in a family) are common, the presence of affected relatives is not obligatory for the diagnosis. Muscle histopathology typically shows rimmed vacuoles and characteristic filamentous inclusions. <italic toggle="yes">GNE</italic>, which encodes the bifunctional enzyme UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, is the only gene in which mutations are known to cause <italic toggle="yes">GNE</italic>-related myopathy.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Treatment is symptomatic. Individuals are often evaluated and managed by a multidisciplinary team including neurologists, geneticists and physiatrists, as well as physical and occupational therapists. All affected individuals should consult their physician before beginning an exercise program.</p>
          <p><italic toggle="yes">Surveillance:</italic> Annual routine follow up with the multidisciplinary team, including screening for signs and symptoms of cardiac and respiratory dysfunction.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid</italic>: Medications/drugs with potential myotoxicity should be used with caution.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">GNE</italic>-related myopathy is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and prenatal testing for pregnancies at increased risk are possible if the disease-causing mutations in the family are known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="ibm.Diagnosis">
        <title>Diagnosis</title>
        <sec id="ibm.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The following clinical diagnostic criteria for <italic toggle="yes">GNE</italic>-related myopathy have been proposed [<xref ref-type="bibr" rid="ibm.REF.griggs.1995.705">Griggs et al 1995</xref>, <xref ref-type="bibr" rid="ibm.REF.argov.2003.1519">Argov et al 2003</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>A primary skeletal muscle disease, usually presenting with weakness in the legs</p>
            </list-item>
            <list-item>
              <p>Sustained quadriceps sparing despite marked weakness of all other proximal lower-extremity muscles</p>
            </list-item>
            <list-item>
              <p>Onset in late teenage years or early adulthood</p>
            </list-item>
            <list-item>
              <p>Modest elevation of serum creatine kinase activity, between two and four times the normal value</p>
            </list-item>
            <list-item>
              <p>Muscle biopsy</p>
              <list list-type="bullet">
                <list-item>
                  <p>On cryostat sections, the most prominent finding is the presence of rimmed vacuoles, lined by basophilic granular material on H&#x00026;E staining and purple-red in color with the modified Gomori trichrome stain. The vacuoles themselves do not stain with oil red orange or PAS stains, and lack acid phosphatase activity; however, with the latter, a few vacuoles show faint activity in the periphery. The vacuoles either appear empty or contain granular or amorphous basophilic inclusions or congophilic masses. Fiber size varies, with both atrophic and hypertrophic fibers observed. Endomysial fibrosis may be considerable. Many fibers contain internal myonuclei and fiber splitting occurs [<xref ref-type="bibr" rid="ibm.REF.mizusawa.1987.129">Mizusawa et al 1987</xref>, <xref ref-type="bibr" rid="ibm.REF.sadeh.1993.217">Sadeh et al 1993</xref>].Note: The origin of the rimmed vacuoles and their contents remains controversial. It has been suggested that they may be autophagic in nature, but the lack of acid phosphatase activity argues against this suggestion. Some authors have suggested that they arise from the membranous structures of the cell (SR, T-tubules, Golgi). Others have suggested that they arise when myonuclei burst and discharge their basophilic content into the cytoplasm [<xref ref-type="bibr" rid="ibm.REF.griggs.1995.705">Griggs et al 1995</xref>].</p>
                </list-item>
                <list-item>
                  <p>On ultrastructural analysis, the vacuoles do not appear as empty spaces but are filled with membranous whorls and cytoplasmic debris. Certain fibers harbor cytoplasmic or nuclear tubulo-filamentous inclusions with a diameter of 16-18 nm.</p>
                </list-item>
                <list-item>
                  <p>In general, inflammation is not observed in an affected muscle. However, a modest inflammatory response has been noted in a few individuals [<xref ref-type="bibr" rid="ibm.REF.argov.2003.1519">Argov et al 2003</xref>, <xref ref-type="bibr" rid="ibm.REF.krause.2003.830">Krause et al 2003</xref>, <xref ref-type="bibr" rid="ibm.REF.yabe.2003.384">Yabe et al 2003</xref>] and inflammatory cell invasion of non-necrotic muscle fibers is rarely reported [<xref ref-type="bibr" rid="ibm.REF.krause.2003.830">Krause et al 2003</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Early changes in certain muscle groups (before clinical weakness is detected) visualized by the following [<xref ref-type="bibr" rid="ibm.REF.mizusawa.1987.129">Mizusawa et al 1987</xref>, <xref ref-type="bibr" rid="ibm.REF.sadeh.1993.217">Sadeh et al 1993</xref>]:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Electromyogram showing myopathic motor unit potentials in association with spontaneous activity, similar to the pattern seen in inflammatory myopathies</p>
                </list-item>
                <list-item>
                  <p>CT or MRI examination of muscle showing fatty replacement of muscle</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Normal nerve conduction velocity studies</p>
            </list-item>
          </list>
          <p>Because simplex cases are common, presence of affected relatives is not obligatory for the diagnosis.</p>
        </sec>
        <sec id="ibm.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p><bold>Gene.</bold>
<italic toggle="yes">GNE</italic>, encoding UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, is the only gene in which mutations are known to cause <italic toggle="yes">GNE</italic>-related myopathy [<xref ref-type="bibr" rid="ibm.REF.eisenberg.2001.83">Eisenberg et al 2001</xref>].</p>
          <p>
            <bold>Clinical testing</bold>
          </p>
          <table-wrap id="ibm.T.summary_of_molecular_genetic_testi" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">GNE</italic>-Related Myopathy</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_ibm.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_ibm.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_ibm.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Mutations Detected&#x000a0;<sup>2</sup></th>
                  <th id="hd_h_ibm.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Mutation Detection Frequency by Test Method&#x000a0;<sup>3</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_ibm.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">GNE</italic>
                  </td>
                  <td headers="hd_h_ibm.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Targeted mutation analysis</td>
                  <td headers="hd_h_ibm.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="ibm.T.selected_gne_pathogenic_variants">p.Met712Thr</xref>
                  </td>
                  <td headers="hd_h_ibm.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Middle Eastern Jewish population ~100%&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_ibm.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence / mutation scanning analysis&#x000a0;<sup>5,</sup>&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_ibm.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  <td headers="hd_h_ibm.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">60%-80%&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_ibm.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication testing&#x000a0;<sup>8</sup></td>
                  <td headers="hd_h_ibm.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Exonic or whole-gene deletions&#x000a0;<sup>9</sup></td>
                  <td headers="hd_h_ibm.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="ibm.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="ibm" object-id="ibm.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="ibm.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="ibm.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="ibm.TF.1.3">
                <label>3. </label>
                <p>The ability of the test method used to detect a mutation that is present in the indicated gene</p>
              </fn>
              <fn id="ibm.TF.1.4">
                <label>4. </label>
                <p>The <xref ref-type="table" rid="ibm.T.selected_gne_pathogenic_variants">p.Met712Thr</xref> mutation is predominant in Middle Eastern Jewish individuals but has also been identified in a small number of non-Jewish families [<xref ref-type="bibr" rid="ibm.REF.eisenberg.2003.99">Eisenberg et al 2003</xref>].</p>
              </fn>
              <fn id="ibm.TF.1.5">
                <label>5. </label>
                <p>Sequence analysis and mutation scanning of the entire gene can have similar mutation detection frequencies; however, mutation detection rates for mutation scanning may vary considerably between laboratories depending on the specific protocol used.</p>
              </fn>
              <fn id="ibm.TF.1.6">
                <label>6. </label>
                <p>Examples of mutations detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site mutations; typically, exonic or whole gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="ibm.TF.1.7">
                <label>7. </label>
                <p>Detection rate varies by certainty of clinical diagnosis.</p>
              </fn>
              <fn id="ibm.TF.1.8">
                <label>8. </label>
                <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="ibm.TF.1.9">
                <label>9. </label>
                <p>A large deletion involving exons 1 to 9 has also been reported [<xref ref-type="bibr" rid="ibm.REF.del_bo.2003.113">Del Bo et al 2003</xref>]. The frequency and detection rates are not known.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="ibm.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To confirm/establish the diagnosis in a proband.</bold> Convenient and cost-effective diagnostic algorithm:</p>
          <list list-type="order">
            <list-item>
              <label>1</label>
              <p>History to determine age of onset, pattern of muscle weakness, and progression over time; physical examination with particular attention to quadriceps sparing</p>
            </list-item>
            <list-item>
              <label>2</label>
              <p>Family history and examination of suspected members</p>
            </list-item>
            <list-item>
              <label>3</label>
              <p>Electromyogram to help identify the pattern of muscle involvement</p>
            </list-item>
            <list-item>
              <label>4</label>
              <p>Serum creatine kinase activity</p>
            </list-item>
          </list>
          <p>In an individual with one or more affected family members who presents with the typical clinical phenotype (i.e., distal-onset weakness in early adulthood with progressive, symmetric leg weakness sparing the quadriceps), the following testing should be considered:</p>
          <list list-type="bullet">
            <list-item>
              <p>Sequence analysis of <italic toggle="yes">GNE</italic> (muscle biopsy not required in this case)</p>
            </list-item>
            <list-item>
              <p>In individuals of Middle Eastern Jewish descent, targeted mutation analysis may be performed first, followed by full gene sequencing if two disease causing mutation are not found.</p>
            </list-item>
            <list-item>
              <p>Deletion/duplication testing can be considered if the above tests are normal</p>
            </list-item>
          </list>
          <p>In individuals with no known family history of muscle disease and/or an atypical clinical presentation (such as sparing of the quadriceps), the following testing algorithm should be considered:</p>
          <list list-type="bullet">
            <list-item>
              <p>Muscle biopsy.</p>
            </list-item>
            <list-item>
              <p>If the muscle biopsy demonstrates typical findings of <italic toggle="yes">GNE</italic>-related myopathy, sequence analysis of <italic toggle="yes">GNE</italic> can then be pursued.</p>
            </list-item>
          </list>
          <p>Muscle biopsy may be useful in two additional scenarios:</p>
          <list list-type="bullet">
            <list-item>
              <p>In individuals where genetic testing has revealed previously unreported <italic toggle="yes">GNE</italic> variants of unknown pathogenicity, muscle biopsy may be helpful. If the typical myopathology of <italic toggle="yes">GNE</italic>-related myopathy is demonstrated by the muscle biopsy this would support the pathogenicity of the <italic toggle="yes">GNE</italic> variant.</p>
              <list list-type="bullet">
                <list-item>
                  <p>In individuals with previously unreported <italic toggle="yes">GNE</italic> variants of unknown pathogenicity, analysis of the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase enzyme activity in lymphocytes may also be helpful.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Muscle biopsy is important in any individual with recent onset of weakness to exclude a treatable inflammatory myopathy.</p>
            </list-item>
          </list>
          <p><bold>Carrier testing for at-risk relatives</bold> requires prior identification of the disease-causing mutations in the family.</p>
          <p>Note: Carriers are heterozygotes for this autosomal recessive disorder and are not at risk of developing the disorder.</p>
          <p><bold>Predictive testing</bold> for at-risk asymptomatic adult family members requires prior identification of the disease-causing mutations in the family.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the disease-causing mutations in the family.</p>
        </sec>
      </sec>
      <sec id="ibm.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="ibm.Clinical_Description">
          <title>Clinical Description</title>
          <p>Weakness starts in young adulthood, usually in the second part of the third decade, with a predilection for distal limb muscles. The initial symptom is difficulty with gait as a result of foot drop secondary to anterior tibialis muscle weakness. The weakness spreads and within several years involves thigh and hand muscles. Shoulder girdle muscles are weak, with relative sparing of the triceps. Neck flexors are commonly involved.</p>
          <p>The striking feature is quadriceps sparing even at advanced stages of the disease. However, based on results of molecular genetic testing, it is now recognized that quadriceps sparing is not a constant feature; some individuals without this finding have been identified [<xref ref-type="bibr" rid="ibm.REF.argov.2003.1519">Argov et al 2003</xref>].</p>
          <p>Affected individuals are usually wheelchair bound about 20 years after onset. If quadriceps sparing is incomplete, loss of ambulation tends to occur earlier.</p>
          <p>Ocular, pharyngeal, and cardiac muscles are usually spared. A single affected individual has been described with respiratory involvement resulting in a reduced FEV1 (forced expiratory volume in 1 second) and vital capacity [<xref ref-type="bibr" rid="ibm.REF.weihl.2011.102">Weihl et al 2011</xref>].</p>
          <p>Occasionally, affected individuals may have facial weakness [<xref ref-type="bibr" rid="ibm.REF.argov.1998.1925">Argov et al 1998</xref>].</p>
          <p>Intellectual abilities are unaffected. The impact of <italic toggle="yes">GNE</italic>-related myopathy on life expectancy for affected individuals with modern multidisciplinary medical care is unclear.</p>
        </sec>
        <sec id="ibm.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>To date, more than 60 mutations in <italic toggle="yes">GNE</italic> have been described [reviewed in <xref ref-type="bibr" rid="ibm.REF.huizing.2009">Huizing &#x00026; Krasnewich 2009</xref>]. Because reports of individuals with <italic toggle="yes">GNE</italic>-related myopathy consist mainly of single case reports or relatively small case series, correlations between genotype and phenotype are difficult. However, a recent study of 71 Japanese individuals with <italic toggle="yes">GNE</italic>-related myopathy has suggested that those harboring a homozygous mutation (<xref ref-type="table" rid="ibm.T.selected_gne_pathogenic_variants">p.Val572Leu</xref>) in the N-acetylmannosamine kinase domain have an earlier disease onset than those who are compound heterozygotes for mutations in the epimerase and kinase domains [<xref ref-type="bibr" rid="ibm.REF.moriyoshimura.2012.100">Mori-Yoshimura et al 2012</xref>]. The individuals with two kinase domain mutants were also more frequently nonambulatory. These findings need to be confirmed in other populations.</p>
        </sec>
        <sec id="ibm.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance is probably not 100%; three individuals with two disease-causing mutations were asymptomatic at advanced age. Two were homozygous [<xref ref-type="bibr" rid="ibm.REF.argov.2003.1519">Argov et al 2003</xref>] and one was compound heterozygous [<xref ref-type="bibr" rid="ibm.REF.nishino.2002.1689">Nishino et al 2002</xref>].</p>
        </sec>
        <sec id="ibm.Nomenclature">
          <title>Nomenclature</title>
          <p>The entity of hereditary inclusion body myopathy 2 (h-IBM2) was likely first recognized in Japan. In 1981, Nonaka and coworkers described an autosomal recessive distal myopathy with rimmed vacuoles (DMRV) in the Western literature [<xref ref-type="bibr" rid="ibm.REF.nonaka.1981.141">Nonaka et al 1981</xref>, <xref ref-type="bibr" rid="ibm.REF.sunohara.1989.65">Sunohara et al 1989</xref>]; they give credit to <xref ref-type="bibr" rid="ibm.REF.sasaki.1969.627">Sasaki et al [1969]</xref> and <xref ref-type="bibr" rid="ibm.REF.ideta.1973.579">Ideta et al [1973]</xref> for having previously described in the Japanese literature possibly similar cases.</p>
          <p><xref ref-type="bibr" rid="ibm.REF.argov.1984.33">Argov &#x00026; Yarom [1984]</xref> published nine cases from four Jewish families of Iranian descent of autosomal recessive "rimmed vacuole myopathy" sparing the quadriceps. A larger series of Iranian Jewish individuals with the same disorder was subsequently published by a group from Tel Aviv [<xref ref-type="bibr" rid="ibm.REF.sadeh.1993.217">Sadeh et al 1993</xref>]. The disorder was characterized by progressive distal and proximal weakness and wasting beginning in the legs and sparing the quadriceps, even in advanced stages. The disease was subsequently found in other ethnic groups [<xref ref-type="bibr" rid="ibm.REF.sivakumar.1996.977">Sivakumar &#x00026; Dalakas 1996</xref>]; with the identification of the gene in which mutation is causative [<xref ref-type="bibr" rid="ibm.REF.eisenberg.2001.83">Eisenberg et al 2001</xref>], it became apparent that the disorder was the same disease as DMRV [<xref ref-type="bibr" rid="ibm.REF.nishino.2002.1689">Nishino et al 2002</xref>].</p>
        </sec>
        <sec id="ibm.Prevalence">
          <title>Prevalence</title>
          <p>To date, more than 200 individuals with <italic toggle="yes">GNE</italic>-related myopathy have been described: about 160 of Iranian Jewish descent with the <xref ref-type="table" rid="ibm.T.selected_gne_pathogenic_variants">p.Met712Thr</xref> homozygous founder mutation, 15 Japanese individuals with the <xref ref-type="table" rid="ibm.T.selected_gne_pathogenic_variants">p.Val572Leu</xref> founder mutation, and the remainder with over 60 mutations in compound heterozygous pattern [<xref ref-type="bibr" rid="ibm.REF.huizing.2009">Huizing &#x00026; Krasnewich 2009</xref>].</p>
          <p>In Israel random testing of 75 Iranian Jewish individuals, unrelated to individuals with IBM, identified five carriers [<xref ref-type="bibr" rid="ibm.REF.eisenberg.2001.83">Eisenberg et al 2001</xref>].</p>
          <p>Considering a worldwide Iranian Jewish population of 150,000-300,000 reported by the Iranian Jewish society in Los Angeles and Israel, prevalence rate appears to be between 1:500 and 1:1000 in Iranian Jews.</p>
          <p>Individuals with <italic toggle="yes">GNE</italic>-related myopathy have been reported in Tunisia [<xref ref-type="bibr" rid="ibm.REF.amouri.2005.361">Amouri et al 2005</xref>] and Italy [<xref ref-type="bibr" rid="ibm.REF.broccolini.2004.632">Broccolini et al 2004</xref>]. Mutations in <italic toggle="yes">GNE</italic> have been reported worldwide.</p>
        </sec>
      </sec>
      <sec id="ibm.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Mutations in <italic toggle="yes">GNE</italic> also cause <related-object link-type="booklink" source-id="gene" document-id="sft" document-type="chapter">sialuria</related-object>. In this disorder, the mutations occur at the allosteric site of the epimerase, abolishing the feedback inhibition mechanism by CMP-sialic acid that results in overproduction of sialic acid [<xref ref-type="bibr" rid="ibm.REF.seppala.1999.1563">Seppala et al 1999</xref>]. Affected individuals exhibit variable degrees of developmental delay, coarse facial features, and hepatomegaly. Inheritance is autosomal dominant.</p>
      </sec>
      <sec id="ibm.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Several forms of hereditary inclusion body myopathy (IBM) have been described under various names, each with its own clinical characteristics and ethnic clustering (see <xref ref-type="table" rid="ibm.T.distal_myopathies">Table 2</xref>):</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Inclusion body myopathy 3</bold> (IBM3) (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/605637">605637</ext-link>), reported in a Swedish family, caused by a missense mutation in the gene encoding the myosin heavy chain IIa (chromosome 17p) [<xref ref-type="bibr" rid="ibm.REF.martinsson.2000.14614">Martinsson et al 2000</xref>]</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="ibmpfd" document-type="chapter"><bold>Inclusion body myopathy associated with Paget disease of the bone and/or frontotemporal dementia</bold></related-object><bold>, or IBMPFD,</bold> characterized by adult-onset proximal and distal muscle weakness (clinically resembling a limb-girdle muscular dystrophy syndrome), early-onset Paget disease of the bone (PDB), and premature frontotemporal dementia (FTD). Muscle weakness progresses to involve other limb and respiratory muscles. Cardiac failure and cardiomyopathy have been observed in later stages. PDB involves focal areas of increased bone turnover that typically lead to spine and/or hip pain and localized enlargement and deformity of the long bones; pathologic fractures occasionally occur. Early stages of FTD are characterized by dysnomia, dyscalculia, comprehension deficits, paraphasic errors, and relative preservation of memory; and later stages by inability to speak, auditory comprehension deficits for even one-step commands, alexia, and agraphia. Mean age at diagnosis for muscle disease and PDB is 42 years; for FTD, 55 years. <italic toggle="yes">VCP</italic> is the only gene in which mutations are known to cause IBMPFD. Inheritance is autosomal dominant.</p>
          </list-item>
          <list-item>
            <p><bold>Autosomal dominant limb-girdle muscular dystrophy type 1A</bold> (LGMD1A, OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/159000">159000</ext-link>), which presents with rimmed vacuoles on histologic examination and is caused by mutations in the gene encoding myotilin [<xref ref-type="bibr" rid="ibm.REF.hauser.2000.2141">Hauser et al 2000</xref>]. See <related-object link-type="booklink" source-id="gene" document-id="lgmd-overview" document-type="chapter">Limb-Girdle Muscular Dystrophy Overview</related-object>.</p>
          </list-item>
          <list-item>
            <p><bold>Autosomal recessive limb-girdle muscular dystrophy type 2J</bold> caused by mutations in <italic toggle="yes">TTN</italic>, the gene encoding titin, may also demonstrate rimmed vacuoles [<xref ref-type="bibr" rid="ibm.REF.udd.2005.636">Udd et al 2005</xref>]. See <related-object link-type="booklink" source-id="gene" document-id="lgmd-overview" document-type="chapter">Limb-Girdle Muscular Dystrophy Overview</related-object>.</p>
          </list-item>
          <list-item>
            <p><bold>A French-Canadian familial myopathy</bold>, with changes resembling inclusion body myopathy and periventricular leukoencephalopathy [<xref ref-type="bibr" rid="ibm.REF.cole.1988.1025">Cole et al 1988</xref>, <xref ref-type="bibr" rid="ibm.REF.argov.1998.1925">Argov et al 1998</xref>]</p>
          </list-item>
        </list>
        <table-wrap id="ibm.T.distal_myopathies" position="anchor" orientation="portrait">
          <label>Table 2. </label>
          <caption>
            <p>Distal Myopathies</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_ibm.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Disease Name</th>
                <th id="hd_h_ibm.T.distal_myopathies_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Mean Age at Onset (in Years)</th>
                <th id="hd_h_ibm.T.distal_myopathies_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Initial Muscle Group Involved</th>
                <th id="hd_h_ibm.T.distal_myopathies_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Serum Creatine Kinase Concentration</th>
                <th id="hd_h_ibm.T.distal_myopathies_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Muscle Biopsy</th>
                <th id="hd_h_ibm.T.distal_myopathies_1_1_1_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene (Locus&#x000a0;<sup>1</sup>)</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1 hd_h_ibm.T.distal_myopathies_1_1_1_2 hd_h_ibm.T.distal_myopathies_1_1_1_3 hd_h_ibm.T.distal_myopathies_1_1_1_4 hd_h_ibm.T.distal_myopathies_1_1_1_5 hd_h_ibm.T.distal_myopathies_1_1_1_6" valign="middle" colspan="6" align="left" scope="col" rowspan="1">
                  <bold>Autosomal Dominant</bold>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Welander distal myopathy</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;40</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Distal upper limbs (finger and wrist extensors)</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_4" rowspan="3" valign="middle" align="left" colspan="1">Normal or slightly increased</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Rimmed vacuoles</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">(2p13)</td>
              </tr>
              <tr>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="udd" document-type="chapter">Udd distal myopathy</related-object>
                </td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;35</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">Anterior compartment in legs</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_5" valign="middle" colspan="1" align="left" rowspan="1">&#x000b1; Rimmed vacuoles</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">TTN</italic>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="mfm" document-type="chapter">Zaspopathy</related-object> (Markesbery-Griggs late-onset distal myopathy)</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;40</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_5" valign="middle" colspan="1" align="left" rowspan="1">Vacuolar and myofibrillar myopathy</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">LDB3</italic>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="mfm" document-type="chapter">Distal myotilinopathy</related-object>
                </td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;40</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Posterior &#x0003e; anterior in legs</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Slightly increased</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Vacuolar and myofibrillar</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">MYOT</italic>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="mpd1" document-type="chapter">Laing early-onset distal myopathy</related-object> (MPD1)</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;20</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Anterior compartment in legs and neck flexors</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Moderately increased</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Type 1 fiber atrophy in tibial anterior muscles; disproportion in proximal muscles</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">MYH7</italic>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Distal myopathy with vocal cord and pharyngeal signs (MPD2)</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">35-60</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Asymmetric lower leg and hands; dysphonia</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">1-8 times</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Rimmed vacuoles</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">(5q)</td>
              </tr>
              <tr>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Distal myopathy with pes cavus and areflexia</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">15-50</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Anterior and posterior lower leg; dysphonia and dysphagia</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">2-6 times</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Dystrophic, rimmed vacuoles</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">(19p13)</td>
              </tr>
              <tr>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">New Finnish distal myopathy (MPD3)</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;30</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Hands or anterior lower leg</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">1-4 times</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Dystrophic; rimmed vacuoles; eosinophilic inclusions</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">(8p22-q11 and 12q13-q22)</td>
              </tr>
              <tr>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1 hd_h_ibm.T.distal_myopathies_1_1_1_2 hd_h_ibm.T.distal_myopathies_1_1_1_3 hd_h_ibm.T.distal_myopathies_1_1_1_4 hd_h_ibm.T.distal_myopathies_1_1_1_5 hd_h_ibm.T.distal_myopathies_1_1_1_6" valign="middle" colspan="6" align="left" scope="col" rowspan="1">
                  <bold>Autosomal Recessive</bold>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="miyoshi" document-type="chapter">Miyoshi early-adult-onset myopathy</related-object>
                </td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">19</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Posterior compartment in legs</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;10 times</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Myopathic changes</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">DYSF</italic>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="ano5-md" document-type="chapter">Miyoshi muscular dystrophy 3</related-object> (MMD3)</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">20-25</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Posterior compartment in legs , asymmetry</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;10 times</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Myopathic changes and, infrequently, rimmed vacuoles</td>
                <td headers="hd_h_ibm.T.distal_myopathies_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">ANO5</italic>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Modified from <xref ref-type="bibr" rid="ibm.REF.udd.2001.561">Udd &#x00026; Griggs [2001]</xref></p>
            </fn>
            <fn id="ibm.TF.2.1">
              <label>1. </label>
              <p>Locus given only if gene is unknown</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Myopathology.</bold> Rimmed vacuoles are induced by freezing of muscle for preparation of cryostat sections. On plastic embedded semi-thin sections, corresponding areas do not appear as vacuoles but contain clusters of refractile granules, composed of membranous whorls as seen on electron microscopy. Such structures are nonspecific, as they can be found in many unrelated diseases including <related-object link-type="booklink" source-id="gene" document-id="opmd" document-type="chapter">oculopharyngeal muscular dystrophy</related-object> [<xref ref-type="bibr" rid="ibm.REF.abubaker.2007.173">Abu-Baker &#x00026; Rouleau 2007</xref>], sporadic inclusion body myositis [<xref ref-type="bibr" rid="ibm.REF.karpati.2009.7">Karpati &#x00026; O&#x02019;Ferrall 2009</xref>], zaspopathy (Markesbery-Griggs-Udd myopathy) [<xref ref-type="bibr" rid="ibm.REF.markesbery.1977.727">Markesbery et al 1977</xref>, <xref ref-type="bibr" rid="ibm.REF.borg.1991.102">Borg et al 1991</xref>, <xref ref-type="bibr" rid="ibm.REF.lindberg.1991.76">Lindberg et al 1991</xref>, <xref ref-type="bibr" rid="ibm.REF.udd.1993.604">Udd et al 1993</xref>], familial inclusion body myopathy 3 [<xref ref-type="bibr" rid="ibm.REF.martinsson.2000.14614">Martinsson et al 2000</xref>], LGMD2J [<xref ref-type="bibr" rid="ibm.REF.udd.2005.636">Udd et al 2005</xref>], and LGMD 1A [<xref ref-type="bibr" rid="ibm.REF.hauser.2000.2141">Hauser et al 2000</xref>]. They can be generated experimentally by chloroquine [<xref ref-type="bibr" rid="ibm.REF.macdonald.1970.479">Macdonald &#x00026; Engel 1970</xref>] or vincristine [<xref ref-type="bibr" rid="ibm.REF.clarke.1972.247">Clarke et al 1972</xref>] and are even found in chronic denervating conditions [<xref ref-type="bibr" rid="ibm.REF.fukuhara.1980.229">Fukuhara et al 1980</xref>].</p>
      </sec>
      <sec id="ibm.Management_1">
        <title>Management</title>
        <sec id="ibm.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with <italic toggle="yes">GNE</italic>-related myopathy, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic examination</p>
            </list-item>
            <list-item>
              <p>Medical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="ibm.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Treatment is symptomatic only:</p>
          <list list-type="bullet">
            <list-item>
              <p>Individuals with <italic toggle="yes">GNE</italic>-related myopathy may benefit from consultation with physiatrists, physiotherapists, and occupational therapists.</p>
            </list-item>
            <list-item>
              <p>Foot drop bracing and other mechanical aids may improve the function of individuals with <italic toggle="yes">GNE</italic>-related myopathy.</p>
            </list-item>
            <list-item>
              <p>Consultation with a pulmonologist to evaluate for nocturnal hypoventilation or sleep apnea may be considered in symptomatic individuals.</p>
            </list-item>
            <list-item>
              <p>All affected individuals should consult their physician before beginning an exercise program.</p>
            </list-item>
          </list>
        </sec>
        <sec id="ibm.Prevention_of_Primary_Manifestations">
          <title>Prevention of Primary Manifestations</title>
          <p>No treatment that reverses or slows the natural history of muscle weakness in <italic toggle="yes">GNE</italic>-related myopathy is available.</p>
        </sec>
        <sec id="ibm.Surveillance">
          <title>Surveillance</title>
          <p>Annual routine follow-up with the multidisciplinary team is recommended. Affected individuals should be screened for signs and symptoms of cardiac dysfunction, as two affected siblings with cardiomyopathy have been reported [<xref ref-type="bibr" rid="ibm.REF.chai.2011.133">Chai et al 2011</xref>]. Affected individuals should also be evaluated for respiratory dysfunction, with appropriate investigations and treatment as needed.</p>
        </sec>
        <sec id="ibm.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>It may be prudent to use medications/drugs with potential myotoxicity (for example: colchicine) with caution.</p>
        </sec>
        <sec id="ibm.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="ibm.Related_Genetic_Counseling_Issues">Related Genetic Counseling Issues</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="ibm.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Several therapies are under investigation for <italic toggle="yes">GNE</italic>-related myopathy including oral sialic acid or its metabolites, intravenous immune globulin and gene replacement therapy.</p>
          <p>Some investigators believe that the reduction of the sialylation status of glycoproteins in muscle of individuals with <italic toggle="yes">GNE</italic>-related myopathy is causative of the disease [<xref ref-type="bibr" rid="ibm.REF.huizing.2004.196">Huizing et al 2004</xref>, <xref ref-type="bibr" rid="ibm.REF.noguchi.2004.11402">Noguchi et al 2004</xref>, <xref ref-type="bibr" rid="ibm.REF.saito.2004.158">Saito et al 2004</xref>]. Muscle atrophy and weakness in a mouse model of <italic toggle="yes">GNE</italic>-related myopathy are prevented by administration of sialic acid metabolites [<xref ref-type="bibr" rid="ibm.REF.malicdan.2009.690">Malicdan et al 2009</xref>]. Several oral exogenous forms of sialic acid (e.g., sialic acid-extended release and N-acetylmannosaminic acid) are currently being investigated in clinical trials for human <italic toggle="yes">GNE</italic>-related myopathy (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov">ClinicalTrials.gov</ext-link> for details).</p>
          <p>Intravenous immune globulin (IVIG) is a glycoprotein which can be metabolized by neuraminidase to provide free sialic acid. A single trial of IVIG in four affected individuals resulted in mild improvement in muscle strength [<xref ref-type="bibr" rid="ibm.REF.sparks.2007.3">Sparks et al 2007</xref>].</p>
          <p>A single affected individual has been treated with intramuscular injections of a GNE expression vector in a lipoplex vehicle [<xref ref-type="bibr" rid="ibm.REF.nemunaitis.2010.403">Nemunaitis et al 2010</xref>]. The same person was later treated with intravenous infusion of the GNE-lipoplex preparation [<xref ref-type="bibr" rid="ibm.REF.nemunaitis.2011.1331">Nemunaitis et al 2011</xref>]. No conclusions can yet be made about the efficacy of such treatment. Reported side effects of the latter treatment included low-grade fever, tachycardia, myalgia, transaminase elevation, hyponatremia, and hypotension. Further studies are required before these therapies will be available for widespread use.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="ibm.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="ibm.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">GNE</italic>-related myopathy is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="ibm.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Parents of an affected individual are obligate heterozygotes; therefore, each carries one of the <italic toggle="yes">GNE</italic> alleles present in the proband.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with a <italic toggle="yes">GNE</italic>-related myopathy are obligate heterozygotes (carriers) of one of the <italic toggle="yes">GNE</italic> pathogenic variants present in the proband.</p>
          <p><bold>Other family members of a proband.</bold> Each unaffected sib of the proband's parents is at a 50% risk of being a carrier.</p>
        </sec>
        <sec id="ibm.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk family members is possible if the pathogenic variants in the family are known.</p>
        </sec>
        <sec id="ibm.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="ibm.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If the <italic toggle="yes">GNE</italic> pathogenic variants have been identified in the family, prenatal diagnosis for pregnancies at increased risk may be available through laboratories that offer either testing for this gene or custom testing.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the pathogenic variants have been identified.</p>
        </sec>
      </sec>
      <sec id="ibm.Resources">
        <title>Resources</title>
      </sec>
      <sec id="ibm.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="ibm.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase is the key enzyme in the biosynthetic pathway of sialic acids, which are the most abundant terminal monosaccharides on glycoconjugates in eukaryotic cells. The first two steps of sialic acid biosynthesis are catalyzed by each one of the two distinct functional domains of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase. First, the UDP-GlcNAc 2-epimerase domain forms ManNAc from UDP-GlcNAc with simultaneous release of UDP. ManNAc is then phosphorylated at C6 by a specific kinase; subsequently, sialic acid is formed by condensation of N-acetylmannosamine-6-phosphate and phosphoenolpyruvate, and activated by CTP to form CMP-sialic acid [<xref ref-type="bibr" rid="ibm.REF.effertz.1999.28771">Effertz et al 1999</xref>].</p>
          <p><bold>Gene structure.</bold> Alternative splicing of <italic toggle="yes">GNE</italic> results in transcript variants encoding different isoforms. The transcript variant <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_005476.5">NM_005476.5</ext-link> has 12 exons and a length of 5329 base pairs (see also Ensembl Genome Browser, gene ID <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://uswest.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000159921;r=9:36214438-36277053">ENSG00000159921</ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="ibm" object-id="ibm.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic allelic variants.</bold> More than 60 different <italic toggle="yes">GNE</italic>-related myopathy -causing mutations in <italic toggle="yes">GNE</italic> have been identified to date [reviewed in <xref ref-type="bibr" rid="ibm.REF.broccolini.2002.1808">Broccolini et al 2002</xref>, <xref ref-type="bibr" rid="ibm.REF.nishino.2002.1689">Nishino et al 2002</xref>, <xref ref-type="bibr" rid="ibm.REF.del_bo.2003.113">Del Bo et al 2003</xref>, <xref ref-type="bibr" rid="ibm.REF.eisenberg.2003.99">Eisenberg et al 2003</xref>, <xref ref-type="bibr" rid="ibm.REF.krause.2003.830">Krause et al 2003</xref>, <xref ref-type="bibr" rid="ibm.REF.saito.2004.158">Saito et al 2004</xref>, <xref ref-type="bibr" rid="ibm.REF.huizing.2009">Huizing &#x00026; Krasnewich 2009</xref>]. Most are missense mutations affecting either the epimerase or the kinase domain, although nonsense, splice site, and deletion mutations have been reported. In Middle Eastern Jewish individuals, the homozygous p.Met712Thr mutation is the only mutation identified to date [<xref ref-type="bibr" rid="ibm.REF.eisenberg.2003.99">Eisenberg et al 2003</xref>], and in Japanese individuals, the homozygous p.Val572Leu mutation seems to be more common [<xref ref-type="bibr" rid="ibm.REF.arai.2002.516">Arai et al 2002</xref>], reflecting the respective founder effects. Note, however, that additional mutations, including p.Met712Thr, have been described in individuals of Japanese origin [<xref ref-type="bibr" rid="ibm.REF.tomimitsu.2004.1607">Tomimitsu et al 2004</xref>, <xref ref-type="bibr" rid="ibm.REF.moriyoshimura.2012.100">Mori-Yoshimura et al 2012</xref>]. (For more information, see <related-object source-id="gene" document-id="ibm" object-id="ibm.molgen.TA">Table A</related-object>.)</p>
          <table-wrap id="ibm.T.selected_gne_pathogenic_variants" position="anchor" orientation="portrait">
            <label>Table 3. </label>
            <caption>
              <p>Selected <italic toggle="yes">GNE</italic> Pathogenic Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_ibm.T.selected_gne_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                  <th id="hd_h_ibm.T.selected_gne_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                  <th id="hd_h_ibm.T.selected_gne_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_ibm.T.selected_gne_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.527A&#x0003e;T</td>
                  <td headers="hd_h_ibm.T.selected_gne_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asp176Val</td>
                  <td headers="hd_h_ibm.T.selected_gne_pathogenic_variants_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_005476.5">NM_005476.5</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_005467.1">NP_005467.1</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ibm.T.selected_gne_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1714G&#x0003e;C&#x000a0;<sup>1</sup></td>
                  <td headers="hd_h_ibm.T.selected_gne_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val572Leu</td>
                </tr>
                <tr>
                  <td headers="hd_h_ibm.T.selected_gne_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2135T&#x0003e;C&#x000a0;<sup>1</sup></td>
                  <td headers="hd_h_ibm.T.selected_gne_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Met712Thr</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="ibm.TF.3.1">
                <label>1. </label>
                <p>See <xref ref-type="sec" rid="ibm.Prevalence">Prevalence</xref> for population-specific information.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_005467.1">NP_005467.1</ext-link> an isoform of 722 residues, is the key enzyme in the biosynthetic pathway of sialic acid [<xref ref-type="bibr" rid="ibm.REF.effertz.1999.28771">Effertz et al 1999</xref>]. Sialic acids are the most abundant terminal monosaccharides on glycoconjugates of eukaryotic cells. Sialic acids influence adhesion processes, which play an important role in many cellular functions including cell migration, transformation of tissues, inflammation, wound healing, and metastasis. The first step of sialic acid biosynthesis is the formation of ManNAc from UDPGlcNAc with the simultaneous release of UDP. ManNAc is then phosphorylated by a specific kinase. These two steps are synthesized by the bifunctional enzyme UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase [<xref ref-type="bibr" rid="ibm.REF.effertz.1999.28771">Effertz et al 1999</xref>], which is highly conserved among mammalian species. In the following steps, sialic acid is formed by condensation of ManNAc-6-phosphate and phosphoenolpyruvate and activated by CTP to form CMP-sialic acid. This nucleotide sugar is finally used as a substrate of sialyltransferases in glycoconjugate biosynthesis [<xref ref-type="bibr" rid="ibm.REF.penner.2006.2968">Penner et al 2006</xref>].</p>
          <p><bold>Abnormal gene product.</bold> Mutations at the allosteric site of the epimerase abolish the feedback inhibition by CMP-sialic acid, resulting in overproduction of sialic acid and leading to the childhood disease <related-object link-type="booklink" source-id="gene" document-id="sft" document-type="chapter">sialuria</related-object>, an entity distinct from <italic toggle="yes">GNE</italic>-related myopathy (see <xref ref-type="sec" rid="ibm.Genetically_Related_Allelic_Disorder">Genetically Related Disorders</xref>) [<xref ref-type="bibr" rid="ibm.REF.seppala.1999.1563">Seppala et al 1999</xref>]. At the current time, it is unclear why mutations in either the epimerase or kinase moiety lead to the phenotype seen in <italic toggle="yes">GNE</italic>-related myopathy skeletal muscle (see also discussion in <xref ref-type="sec" rid="ibm.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>).</p>
          <p>Residual enzyme activity is essential for life; complete lack of enzyme activity as demonstrated by inactivation of <italic toggle="yes">GNE</italic> in mice is lethal in early embryonic stages [<xref ref-type="bibr" rid="ibm.REF.schwarzkopf.2002.5267">Schwarzkopf et al 2002</xref>]. The crystal structure of the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase has recently been solved [<xref ref-type="bibr" rid="ibm.REF.tong.2009.e7165">Tong et al 2009</xref>] and should provide insights into the effect of disease-causing mutations.</p>
          <p>It is hypothesized that reduced enzymatic activity is responsible for the skeletal muscle phenotype, although this remains a matter of controversy. Hypoglycosylation of alpha-dystroglycan can lead to neurologic syndromes with prominent involvement of skeletal muscle including Walker-Warburg syndrome (WWS), muscle-eye-brain disease (MEBD), <related-object link-type="booklink" source-id="gene" document-id="fcmd" document-type="chapter">Fukuyama congenital muscular dystrophy</related-object> (FCMD), congenital muscular dystrophy type 1C (CMD1C), congenital muscular dystrophy type 1D (CMD1D; see <related-object link-type="booklink" source-id="gene" document-id="cmd-overview" document-type="chapter">Congenital Muscular Dystrophy Overview</related-object>), limb-girdle-muscular dystrophy type 2I (LGMD2I), and limb-girdle-muscular dystrophy type 2K (LGMD2K; see <related-object link-type="booklink" source-id="gene" document-id="lgmd-overview" document-type="chapter">Limb-Girdle Muscular Dystrophy Overview</related-object>); thus, it is tempting to speculate that mutations in <italic toggle="yes">GNE</italic> would influence the glycosylation status of alpha-dystroglycan or other skeletal muscle proteins. Several laboratories have studied the glycosylation pattern in skeletal muscle and cultured muscle cells from individuals with <italic toggle="yes">GNE</italic>-related myopathy. Some laboratories have found a reduction of the sialylation status in muscle of individuals with <italic toggle="yes">GNE</italic>-related myopathy [<xref ref-type="bibr" rid="ibm.REF.huizing.2004.196">Huizing et al 2004</xref>, <xref ref-type="bibr" rid="ibm.REF.noguchi.2004.11402">Noguchi et al 2004</xref>, <xref ref-type="bibr" rid="ibm.REF.saito.2004.158">Saito et al 2004</xref>], while others have not [<xref ref-type="bibr" rid="ibm.REF.salama.2005.221">Salama et al 2005</xref>].</p>
          <p>A mouse model for <italic toggle="yes">GNE</italic>-related myopathy has been generated by expressing the human <italic toggle="yes">GNE</italic> disease allele <xref ref-type="table" rid="ibm.T.selected_gne_pathogenic_variants">p.Asp176Val</xref> as a transgene on a mouse <italic toggle="yes">Gne</italic> knockout background [<xref ref-type="bibr" rid="ibm.REF.malicdan.2007.2669">Malicdan et al 2007</xref>]. The myopathology is similar to that seen in humans and demonstrates scattered small angular fibers, inclusion bodies, and accumulation of several aberrant molecules (beta amyloid, beta-amyloid precursor protein, tau, phosphorylated neurofilaments, proteins of the unfolded protein response, and ubiquitin). The mice exhibit marked hyposialylation. Stimulation of sialylation delayed the muscle atrophy and weakness [<xref ref-type="bibr" rid="ibm.REF.malicdan.2009.690">Malicdan et al 2009</xref>].</p>
          <p>A second mouse model for <italic toggle="yes">GNE</italic>-related myopathy was generated by introduction of the p.Met712Thr kinase domain mutation into the endogenous mouse gene <italic toggle="yes">Gne</italic> [<xref ref-type="bibr" rid="ibm.REF.galeano.2007.1585">Galeano et al 2007</xref>]. Surprisingly, this mouse model did not recapitulate the human muscle disease since the mice died within the first 72 hours of life from renal disease (glomerular podocytopathology). However is it interesting to note that the phenotype was rescued by administration of an oral sialic acid precursor, thus supporting the hypothesis that the biochemical defect is related to reduced sialylation.</p>
          <p><xref ref-type="bibr" rid="ibm.REF.broccolini.2008.971">Broccolini et al [2008]</xref> found that neprilysin, a metallopeptidase that cleaves beta-amyloid is hyposialylated in <italic toggle="yes">GNE</italic>-related myopathy and has reduced enzymatic activity when hyposialylated. The authors hypothesize that hyposialylated neprilysin may reduce beta-amyloid clearance and contribute to its accumulation in muscle fibers.</p>
          <p>Data from the proteomic profile of patients with <italic toggle="yes">GNE</italic>-related myopathy may yield further insights into the pathophysiology. <xref ref-type="bibr" rid="ibm.REF.sela.2011.e16334">Sela et al [2011]</xref> found that proteins involved in ubiquitination, stress response, mitochondrial processes and cytoskeleton and sarcomere organization may be involved in <italic toggle="yes">GNE</italic>-related myopathy.</p>
        </sec>
      </sec>
      <sec id="ibm.References">
        <title>References</title>
        <sec id="ibm.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="ibm.Literature_Cited.reflist0">
            <ref id="ibm.REF.abubaker.2007.173">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abu-Baker</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouleau</surname>
                    <given-names>GA</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Oculopharyngeal muscular dystrophy: recent advances in the underdstanding of the molecular pathogenic mechanisms and treatment strategies.</article-title>
                <source>Biochim Biophys Acta</source>
                <volume>1772</volume>
                <fpage>173</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">17110089</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.amouri.2005.361">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Amouri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Driss</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murayama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kefi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Allelic heterogeneity of GNE gene mutation in two Tunisian families with autosomal recessive inclusion body myopathy.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>15</volume>
                <fpage>361</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15833430</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.arai.2002.516">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeuchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Igarashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asaka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Date</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawasaki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uyama</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizusawa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukuhara</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>A novel mutation in the GNE gene and a linkage disequilibrium in Japanese pedigrees.</article-title>
                <source>Ann Neurol</source>
                <volume>52</volume>
                <fpage>516</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12325084</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.argov.2003.1519">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Argov</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisenberg</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grabov-Nardini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadeh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wirguin</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soffer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitrani-Rosenbaum</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Hereditary inclusion body myopathy: The Middle Eastern genetic cluster.</article-title>
                <source>Neurology</source>
                <volume>60</volume>
                <fpage>1519</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">12743242</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.argov.1998.1925">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Argov</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadeh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisenberg</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karpati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitrani-Rosenbaum</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Facial weakness in hereditary inclusion body myopathies.</article-title>
                <source>Neurology</source>
                <volume>50</volume>
                <fpage>1925</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9633772</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.argov.1984.33">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Argov</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yarom</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1984</year>
                <article-title>"Rimmed vacuole myopathy" sparing the quadriceps. A unique disorder in Iranian Jews.</article-title>
                <source>J Neurol Sci</source>
                <volume>64</volume>
                <fpage>33</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">6737002</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.borg.1991.102">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Borg</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tome</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edstrom</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Intranuclear and cytoplasmic filamentous inclusions in distal myopathy (Welander).</article-title>
                <source>Acta Neuropathol (Berl)</source>
                <volume>82</volume>
                <fpage>102</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">1656692</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.broccolini.2008.971">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Broccolini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gidaro</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Cristofaro</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morosetti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gliubizzi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricci</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonali</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mirabella</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle.</article-title>
                <source>J Neurochem.</source>
                <year>2008</year>
                <month>May</month>
                <volume>105</volume>
                <issue>3</issue>
                <fpage>971</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">18182043</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.broccolini.2002.1808">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Broccolini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pescatori</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Amico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silvestri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricci</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Servidei</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonali</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mirabella</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene.</article-title>
                <source>Neurology</source>
                <volume>59</volume>
                <fpage>1808</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12473780</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.broccolini.2004.632">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Broccolini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricci</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassandrini</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gliubizzi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruno</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonoli</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silvestri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pescatori</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodolico</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sinicropi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Servidei</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minetti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonali</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mirabella</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Novel GNE mutations in Italian families with autosomal recessive hereditary inclusion-body myopathy.</article-title>
                <source>Hum Mutat</source>
                <volume>23</volume>
                <fpage>632</fpage>
                <pub-id pub-id-type="pmid">15146476</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.chai.2011.133">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chai</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertorini</surname>
                    <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrew</surname>
                    <given-names>FA</given-names>
                  </name>
                </person-group>
                <article-title>Hereditary inclusion-body myopathy associated with cardiomyopathy: report of two siblings.</article-title>
                <source>Muscle Nerve.</source>
                <year>2011</year>
                <month>Jan</month>
                <volume>43</volume>
                <fpage>133</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21082694</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.clarke.1972.247">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Clarke</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karpati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolfe</surname>
                    <given-names>LS</given-names>
                  </name>
                </person-group>
                <year>1972</year>
                <article-title>The effect of vincristine on skeletal muscle in the rat. A correlative histochemical, ultrastructural and chemical study.</article-title>
                <source>J Neuropathol Exp Neurol</source>
                <volume>31</volume>
                <fpage>247</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">4112664</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.cole.1988.1025">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuzniecky</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karpati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>1988</year>
                <article-title>Familial myopathy with changes resembling inclusion body myositis and periventricular leucoencephalopathy. A new syndrome.</article-title>
                <source>Brain</source>
                <volume>111</volume>
                <fpage>1025</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">2846114</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.del_bo.2003.113">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Del Bo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baron</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serafini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moggio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fonzo</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castagni</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresolin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>GP</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Novel missense mutation and large deletion of GNE gene in autosomal-recessive inclusion-body myopathy.</article-title>
                <source>Muscle Nerve</source>
                <volume>28</volume>
                <fpage>113</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12811782</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.effertz.1999.28771">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Effertz</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hinderlich</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reutter</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Selective loss of either the epimerase or kinase activity of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase due to site-directed mutagenesis based on sequence alignments.</article-title>
                <source>J Biol Chem</source>
                <volume>274</volume>
                <fpage>28771</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10497249</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.eisenberg.2001.83">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eisenberg</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avidan</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potikha</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hochner</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olender</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barash</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shemesh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadeh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grabov-Nardini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shmilevich</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedmann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karpati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradley</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumbach</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lancet</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asher</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Argov</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitrani-Rosenbaum</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy.</article-title>
                <source>Nat Genet</source>
                <volume>29</volume>
                <fpage>83</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11528398</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.eisenberg.2003.99">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eisenberg</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grabov-Nardini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hochner</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadeh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertorini</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castellan</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Felice</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendell</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merlini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shilling</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wirguin</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Argov</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitrani-Rosenbaum</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Mutations spectrum of GNE in hereditary inclusion body myopathy sparing the quadriceps.</article-title>
                <source>Hum Mutat</source>
                <volume>21</volume>
                <fpage>99</fpage>
                <pub-id pub-id-type="pmid">12497639</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.fukuhara.1980.229">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fukuhara</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumamoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsubaki</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1980</year>
                <article-title>Rimmed vacuoles.</article-title>
                <source>Acta Neuropathol (Berl)</source>
                <volume>51</volume>
                <fpage>229</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">7445977</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.galeano.2007.1585">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Galeano</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klootwijk</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manoli</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciccone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darvish</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Starost</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerfas</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>VJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoogstraten-Miller</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krasnewich</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahl</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huizing</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine.</article-title>
                <source>J Clin Invest.</source>
                <year>2007</year>
                <month>Jun</month>
                <volume>117</volume>
                <issue>6</issue>
                <fpage>1585</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">17549255</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.griggs.1995.705">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Griggs</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Askanas</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karpati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendell</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rowland</surname>
                    <given-names>LP</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Inclusion body myositis and myopathies.</article-title>
                <source>Ann Neurol</source>
                <volume>38</volume>
                <fpage>705</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">7486861</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.hauser.2000.2141">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hauser</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horrigan</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salmikangas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torian</surname>
                    <given-names>UM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viles</surname>
                    <given-names>KD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dancel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tim</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taivainen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartoloni</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilchrist</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stajich</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaskell</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilbert</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vance</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pericak-Vance</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpen</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westbrook</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Speer</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Myotilin is mutated in limb girdle muscular dystrophy 1A.</article-title>
                <source>Hum Mol Genet</source>
                <volume>9</volume>
                <fpage>2141</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10958653</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.huizing.2009">
              <mixed-citation publication-type="other">Huizing M, Krasnewich DM. Hereditary inclusion body myopathy: a decade of progress. Biochim Biophys Acta. 2009;1792:881-7.</mixed-citation>
            </ref>
            <ref id="ibm.REF.huizing.2004.196">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huizing</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rakocevic</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sparks</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mamali</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shatunov</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldfarb</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krasnewich</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahl</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalakas</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Hypoglycosylation of alpha-dystroglycan in patients with hereditary IBM due to GNE mutations.</article-title>
                <source>Mol Genet Metab</source>
                <volume>81</volume>
                <fpage>196</fpage>
                <lpage>202</lpage>
                <pub-id pub-id-type="pmid">14972325</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.ideta.1973.579">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ideta</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shikai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchino</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okajima</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akatsuka</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1973</year>
                <article-title>Distal myopathy--evaluation of 4 cases in 2 families.</article-title>
                <source>Rinsho Shinkeigaku.</source>
                <volume>13</volume>
                <fpage>579</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">4798256</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.karpati.2009.7">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Karpati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O&#x02019;Ferrall</surname>
                    <given-names>EK</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Sporadic inclusion body myositis: pathogenic considerations.</article-title>
                <source>Ann Neurol</source>
                <volume>65</volume>
                <fpage>7</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">19194875</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.krause.2003.830">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Krause</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlotter-Weigel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Najmabadi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiendl</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller-H&#x000f6;cker</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller-Felber</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pongratz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>A novel homozygous missense mutation in the GNE gene of a patient with quadriceps-sparing hereditary inclusion body myopathy associated with muscle inflammation.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2003</year>
                <month>Dec</month>
                <volume>13</volume>
                <issue>10</issue>
                <fpage>830</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">14678807</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.lindberg.1991.76">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lindberg</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borg</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edstrom</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hedstrom</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oldfors</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Inclusion body myositis and Welander distal myopathy: a clinical, neurophysiological and morphological comparison.</article-title>
                <source>J Neurol Sci</source>
                <volume>103</volume>
                <fpage>76</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">1650819</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.macdonald.1970.479">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Macdonald</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>1970</year>
                <article-title>Experimental chloroquine myopathy.</article-title>
                <source>J Neuropathol Exp Neurol</source>
                <volume>29</volume>
                <fpage>479</fpage>
                <lpage>99</lpage>
                <pub-id pub-id-type="pmid">4247107</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.malicdan.2009.690">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Malicdan</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noguchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>YK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <article-title>Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model.</article-title>
                <source>Nat Med.</source>
                <year>2009</year>
                <month>Jun</month>
                <volume>15</volume>
                <fpage>690</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19448634</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.malicdan.2007.2669">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Malicdan</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noguchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>YK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.</article-title>
                <source>Hum Mol Genet</source>
                <volume>16</volume>
                <fpage>2669</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">17704511</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.markesbery.1977.727">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Markesbery</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griggs</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herr</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>1977</year>
                <article-title>Distal myopathy: electron microscopic and histochemical studies.</article-title>
                <source>Neurology</source>
                <volume>27</volume>
                <fpage>727</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">196233</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.martinsson.2000.14614">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Martinsson</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oldfors</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berg</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tajsharghi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kyllerman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wahlstrom</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Autosomal dominant myopathy: missense mutation (Glu-706 --&#x0003e; Lys) in the myosin heavy chain IIa gene.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>97</volume>
                <fpage>14614</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11114175</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.mizusawa.1987.129">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mizusawa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurisaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takatsu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mannen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toyokura</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakanishi</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1987</year>
                <article-title>Rimmed vacuolar distal myopathy: a clinical, electrophysiological, histopathological and computed tomographic study of seven cases.</article-title>
                <source>J Neurol</source>
                <volume>234</volume>
                <fpage>129</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">3585419</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.moriyoshimura.2012.100">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mori-Yoshimura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monma</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumamoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomimitsu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sonoo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugie</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oya</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>YK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malicdan</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noguchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murata</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <article-title>Heterozygous UDP-GlcNAc 2-epimerase and N-acetylmannosamine kinase domain mutations in the GNE gene result in a less severe GNE myopathy phenotype compared to homozygous N-acetylmannosamine kinase domain mutations.</article-title>
                <source>J Neurol Sci.</source>
                <year>2012</year>
                <month>Jul</month>
                <day>15</day>
                <volume>318</volume>
                <fpage>100</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">22507750</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.nemunaitis.2011.1331">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nemunaitis</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jay</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maples</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahl</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huizing</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yardeni</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tong</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phadke</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pappen</surname>
                    <given-names>BO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bedell</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hernandez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Templeton</surname>
                    <given-names>NS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuhn</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senzer</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nemunaitis</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Hereditary inclusion body myopathy: single patient response to intravenous dosing of GNE gene lipoplex.</article-title>
                <source>Hum Gene Ther.</source>
                <year>2011</year>
                <month>Nov</month>
                <volume>22</volume>
                <fpage>1331</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">21517694</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.nemunaitis.2010.403">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nemunaitis</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maples</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jay</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahl</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huizing</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poling</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tong</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phadke</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pappen</surname>
                    <given-names>BO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bedell</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Templeton</surname>
                    <given-names>NS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuhn</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senzer</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nemunaitis</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Hereditary inclusion body myopathy: single patient response to GNE gene Lipoplex therapy.</article-title>
                <source>J Gene Med.</source>
                <year>2010</year>
                <month>May</month>
                <volume>12</volume>
                <fpage>403</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">20440751</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.nishino.2002.1689">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noguchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murayama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Driss</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugie</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oya</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chida</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takusa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishimiya</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sunohara</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciafaloni</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy.</article-title>
                <source>Neurology</source>
                <volume>59</volume>
                <fpage>1689</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">12473753</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.noguchi.2004.11402">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Noguchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keira</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murayama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawahara</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oya</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imazawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>YK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Reduction of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase activity and sialylation in distal myopathy with rimmed vacuoles.</article-title>
                <source>J Biol Chem</source>
                <volume>279</volume>
                <fpage>11402</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">14707127</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.nonaka.1981.141">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sunohara</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishiura</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Satoyoshi</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1981</year>
                <article-title>Familial distal myopathy with rimmed vacuole and lamellar (myeloid) body formation.</article-title>
                <source>J Neurol Sci</source>
                <volume>51</volume>
                <fpage>141</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">7252518</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.penner.2006.2968">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Penner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mantey</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elgavish</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghaderi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cirak</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krause</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucka</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voit</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitrani-Rosenbaum</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hinderlich</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Influence of UDP-GlcNAc 2-epimerase/ManNAc kinase mutant proteins on hereditary inclusion body myopathy.</article-title>
                <source>Biochemistry</source>
                <volume>45</volume>
                <fpage>2968</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">16503651</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.sadeh.1993.217">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sadeh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gadoth</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadar</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-David</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Vacuolar myopathy sparing the quadriceps.</article-title>
                <source>Brain</source>
                <volume>116</volume>
                <fpage>217</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">8453459</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.saito.2004.158">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomimitsu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakai</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizusawa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumura</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>A Japanese patient with distal myopathy with rimmed vacuoles: missense mutations in the epimerase domain of the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) gene accompanied by hyposialylation of skeletal muscle glycoproteins.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>14</volume>
                <fpage>158</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">14733963</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.salama.2005.221">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Salama</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hinderlich</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shlomai</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisenberg</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krause</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yarema</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Argov</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochmuller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reutter</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dabby</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadeh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Bassat</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitrani-Rosenbaum</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>No overall hyposialylation in hereditary inclusion body myopathy myoblasts carrying the homozygous M712T GNE mutation.</article-title>
                <source>Biochem Biophys Res Commun</source>
                <volume>328</volume>
                <fpage>221</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15670773</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.sasaki.1969.627">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Distal myopathy-report of four cases.</article-title>
                <source>Clin Neurol (Tokyo)</source>
                <year>1969</year>
                <volume>9</volume>
                <fpage>627</fpage>
                <lpage>37</lpage>
              </element-citation>
            </ref>
            <ref id="ibm.REF.schwarzkopf.2002.5267">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schwarzkopf</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knobeloch</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rohde</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hinderlich</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiechens</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucka</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horak</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reutter</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horstkorte</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Sialylation is essential for early development in mice.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>99</volume>
                <fpage>5267</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">11929971</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.sela.2011.e16334">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sela</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milman Krentsis</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shlomai</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadeh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dabby</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Argov</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Bassat</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitrani-Rosenbaum</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>The proteomic profile of hereditary inclusion body myopathy.</article-title>
                <source>PLoS One.</source>
                <year>2011</year>
                <month>Jan</month>
                <day>31</day>
                <volume>6</volume>
                <fpage>e16334</fpage>
                <pub-id pub-id-type="pmid">21305017</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.seppala.1999.1563">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Seppala</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehto</surname>
                    <given-names>VP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahl</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Mutations in the human UDP-N-acetylglucosamine 2-epimerase gene define the disease sialuria and the allosteric site of the enzyme.</article-title>
                <source>Am J Hum Genet</source>
                <volume>64</volume>
                <fpage>1563</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10330343</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.sivakumar.1996.977">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sivakumar</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalakas</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>The spectrum of familial inclusion body myopathies in 13 families and a description of a quadriceps-sparing phenotype in non-Iranian Jews.</article-title>
                <source>Neurology</source>
                <volume>47</volume>
                <fpage>977</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">8857730</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.sparks.2007.3">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sparks</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rakocevic</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joe</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manoli</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shrader</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris-Love</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sonies</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciccone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorward</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krasnewich</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huizing</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalakas</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahl</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <article-title>Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study.</article-title>
                <source>BMC Neurol.</source>
                <year>2007</year>
                <month>Jan</month>
                <day>29</day>
                <volume>7</volume>
                <fpage>3</fpage>
                <pub-id pub-id-type="pmid">17261181</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.sunohara.1989.65">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sunohara</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamei</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Satoyoshi</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1989</year>
                <article-title>Distal myopathy with rimmed vacuole formation. A follow-up study.</article-title>
                <source>Brain</source>
                <volume>112</volume>
                <fpage>65</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">2645018</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.tomimitsu.2004.1607">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tomimitsu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishikawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohkoshi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanazawa</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizusawa</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Distal myopathy with rimmed vacuoles (DMRV): new GNE mutations and splice variant.</article-title>
                <source>Neurology</source>
                <volume>62</volume>
                <fpage>1607</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">15136692</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.tong.2009.e7165">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tong</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tempel</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nedyalkova</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackenzie</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>HW</given-names>
                  </name>
                </person-group>
                <article-title>Crystal structure of the N-acetylmannosamine kinase domain of GNE.</article-title>
                <source>PLoS One.</source>
                <year>2009</year>
                <month>Oct</month>
                <day>20</day>
                <volume>4</volume>
                <fpage>e7165</fpage>
                <pub-id pub-id-type="pmid">19841673</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.udd.2001.561">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Udd</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griggs</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Distal myopathies.</article-title>
                <source>Curr Opin Neurol</source>
                <volume>14</volume>
                <fpage>561</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11562566</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.udd.1993.604">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Udd</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Partanen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halonen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falck</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hakamies</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heikkil&#x000e4;</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ingo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalimo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000e4;&#x000e4;ri&#x000e4;inen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laulumaa</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palj&#x000e4;rvi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rapola</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reunanen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sonninen</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somer</surname>
                    <given-names>H.</given-names>
                  </name>
                </person-group>
                <article-title>Tibial muscular dystrophy. Late adult-onset distal myopathy in 66 Finnish patients.</article-title>
                <source>Arch Neurol.</source>
                <year>1993</year>
                <month>Jun</month>
                <volume>50</volume>
                <issue>6</issue>
                <fpage>604</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8503797</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.udd.2005.636">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Udd</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vihola</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarparanta</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hackman</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J.</article-title>
                <source>Neurology.</source>
                <year>2005</year>
                <month>Feb</month>
                <day>22</day>
                <volume>64</volume>
                <fpage>636</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">15728284</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.weihl.2011.102">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weihl</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaidman</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pestronk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Lozi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Novel GNE mutations in two phenotypically distinct HIBM2 patients.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2011</year>
                <month>Feb</month>
                <volume>21</volume>
                <fpage>102</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21131200</pub-id>
              </element-citation>
            </ref>
            <ref id="ibm.REF.yabe.2003.384">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yabe</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kikuchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukazawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tashiro</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>GNE mutations causing distal myopathy with rimmed vacuoles with inflammation.</article-title>
                <source>Neurology</source>
                <volume>61</volume>
                <fpage>384</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12913203</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="ibm.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="ibm.Author_Notes">
          <title>Author Notes</title>
          <p>George Karpati, MD was a distinguished physician and scientist. A Hungarian-born Holocaust survivor, he became a leading expert in muscular dystrophy and other neuromuscular disorders; he held the IW Killam Chair and was Professor of Neurology and Neurosurgery at McGill University. Dr. Karpati died suddenly on February 6, 2009. He leaves behind family and many close friends in Canada, the United States, Israel, and Hungary.</p>
        </sec>
        <sec id="ibm.Acknowledgments">
          <title>Acknowledgments</title>
          <p>This study was supported by the Canadian Institutes of Health Research, the Muscular Dystrophy Association of Canada and USA, the Association Fran&#x000e7;aise contre les Myopathies, the Geneva University Hospital, and the Lichtensteinstiftung, Basel, Switzerland.</p>
        </sec>
        <sec id="ibm.Author_History">
          <title>Author History</title>
          <p>Erin O&#x02019;Ferrall, MD, MSc, FRCPC (2009-present)George Karpati, MD, FRCP(C), FRS(C), OC; McGill University (2004-2009)Michael Sinnreich, MD, PhD (2004-present)</p>
        </sec>
        <sec id="ibm.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>7 March 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>6 August 2009 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>24 May 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>26 March 2004 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>17 November 2003 (gk) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
